Rebeca De Los Ángeles Sierra

Dr. Rebeca De Los Ángeles Sierra

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2024 in Livers
Verified
Journal Article
Open access
PDF file
Rebeca De Los Ángeles SierraRebeca De Los Ángeles Sierra
Rebeca De Los Ángeles Sierra
AMAna Marenco
Ana Marenco
MAMarwan Alsaqa
Marwan Alsaqa
RBRomelia Barba
Romelia Barba
MCMarcela Cuellar-Lobo
Marcela Cuellar-Lobo
Leandro Luis Sierra CarreroLeandro Luis Sierra Carrero
Leandro Luis Sierra Carrero
Autoimmune hepatitis (AIH) is a varied inflammatory chronic liver disease. AIH’s prevalence varies and has increased recently. Diagnosis involves the discovery of histologic features following liver biopsy and serologic testing. Clinical features vary, and up to 40% of patients may be asymptomatic. Evaluating thiopurine methyltransferase (TMPM) activity before treatment is crucial for an optimal response. The primary treatment goal is biochemical remission, normalized serum IgG, and liver enzymes. Induction therapy typically involves azathioprine and corticosteroids. Close monitoring of liver function tests and serum immunoglobulin levels is essential. Medications can be tapered after achieving biochemical remission. Liver transplantation may be required for refractory disease or cirrhosis. Further therapeutic approaches are needed, particularly for non-responders to first-line treatments.